Stocks and Investing
Stocks and Investing
Thu, October 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Tanquilut Maintained (CCRN) at Strong Buy with Decreased Target to $32 on, Oct 5th, 2023
Brian Tanquilut of Jefferies, Maintained "Cross Country Healthcare, Inc." (CCRN) at Strong Buy with Decreased Target from $40 to $32 on, Oct 5th, 2023.
Brian has made no other calls on CCRN in the last 4 months.
There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023
These are the ratings of the 2 analyists that currently disagree with Brian
- Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $29 on, Monday, August 14th, 2023
- Trevor Romeo of "William Blair" Initiated at Buy on, Monday, June 26th, 2023
Contributing Sources